SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-20-000057
Filing Date
2020-11-05
Accepted
2020-11-05 16:09:04
Documents
57
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cdtx-20200930.htm   iXBRL 10-Q 1416858
2 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit311q32020ng.htm EX-31.1 9938
3 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit312q32020ng.htm EX-31.2 9777
4 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit321q32020ng.htm EX-32.1 7633
5 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit322q32020ng.htm EX-32.2 7623
  Complete submission text file 0001610618-20-000057.txt   5880915

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20200930.xsd EX-101.SCH 40649
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20200930_cal.xml EX-101.CAL 58965
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20200930_def.xml EX-101.DEF 203623
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20200930_lab.xml EX-101.LAB 507067
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20200930_pre.xml EX-101.PRE 330815
11 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20200930_htm.xml XML 886080
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 201290499
SIC: 2836 Biological Products, (No Diagnostic Substances)